SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Xechem International

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: GatewayStocks3/1/2006 8:37:14 AM
   of 75
 
Stockguru.com: Guru Alert for Wednesday, March 1, 2006 XKEM

Wednesday, March 01, 2006 03:36 ET

Dallas, Texas, Mar 01, 2006 (M2 PRESSWIRE via COMTEX) -- Stock Guru Alert for Wednesday Xechem International, Inc. (OTCBB:XKEM)

Xechem International, Inc. (OTCBB:XKEM) closed down at 4.58%, trading 84,950,250 shares on Tuesday.

Xechem International, Inc. is a development stage biopharmaceutical company focusing on anticancer, antiviral (including AIDS), antifungal, Sickle Cell Disease (SCD), antimalarial and antibacterial products from natural sources, including microbial and marine organisms. Xechem's mission is to bring relief to the millions of people who suffer from these diseases. Its focus is on the development of phyto-pharmaceuticals and other proprietary technologies, including those used in the treatment of orphan diseases. Its primary attention and resources are currently being directed toward the development and commercial launch of its Sickle Cell drug, NICOSAN(TM)/HEMOXIN(TM), which has shown efficacy in the treatment of SCD.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext